Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Selleck Chemical LLC AG-13958 S2211-2mg
Supplier: Selleck Chemical LLC S22112MG
AG-13958 (AG-013958) a VEGFR tyrosine kinase inhibitor is in clinical development with ST administration for treatment of choroidal neovascularization associated with age related macular degeneration (AMD)
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?